Skin as a route of exposure and sensitization in chronic beryllium disease - Wikidata - wikimedia - TriplyDB

Skin as a route of exposure and sensitization in chronic beryllium disease

Skin as a route of exposure and sensitization in chronic beryllium disease

http://www.wikidata.org/entity/Q23920927

about

Q24815376 Q28385307

sameAs

Comment on Strupp papers on beryllium metal toxicity A critical evaluation of material safety data sheets (MSDSs) for engineered nanomaterials Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment Nanotoxicology - a pathologist's perspective Skin exposure to isocyanates: reasons for concern Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model Migration of beryllium via multiple exposure pathways among work processes in four different facilities Toxicology of nanomaterials used in nanomedicine Chronic beryllium disease and sensitization at a beryllium processing facility Trace beryllium determination in polyvinyl alcohol wipes by extraction and fluorescence detection: interlaboratory analysis Evaluation of a standardized micro-vacuum sampling method for collection of surface dust Analytical performance criteria: standardized surface dust sampling methods for metals, with emphasis on beryllium Immune stimulation following dermal exposure to unsintered indium tin oxide Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers Genetic determinants of sensitivity to beryllium in mice Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations Effectiveness of local exhaust ventilation (LEV) in controlling engineered nanomaterial emissions during reactor cleanout operations Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials - Part B: results from 12 field studies Evaluation of the potential airborne release of carbon nanofibers during the preparation, grinding, and cutting of epoxy-based nanocomposite material Release of beryllium from mineral ores in artificial lung and skin surface fluids Nanoparticles: health effects - pros and cons Extraction of beryllium from refractory beryllium oxide with dilute ammonium bifluoride and determination by fluorescence: a multiparameter performance evaluation Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed Potential health effects associated with dermal exposure to occupational chemicals Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposure Human health implications of nanomaterial exposure Occupational exposure to nanomedical applications Beryllium surface levels in a military ammunition plant Applications of nanotechnology in dermatology Effectiveness of a custom-fitted flange and local exhaust ventilation (LEV) system in controlling the release of nanoscale metal oxide particulates during reactor cleanout operations Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Nanoparticles - known and unknown health risks Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility Biosafety, occupational health and nanotechnology In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR Penetration of intact skin by quantum dots with diverse physicochemical properties Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers Convergence of nanotechnology and cancer prevention: are we there yet?Chronic beryllium disease: an updated model interaction between innate and acquired immunity Engineered nanomaterials: exposures, hazards, and risk prevention

P2860

Q23909399-3C0D46BA-2A8B-4A23-96F3-DC1C58D29038 Q23909581-E1D2EEB3-43A5-43E4-8A71-8C48276ACF55 Q23909687-EF7E1CA7-1DCA-44B7-9D02-784B9F1184EC Q23909944-F43F05B0-F73C-4F2D-98BA-CAEB1BE305E3 Q23912082-3DC4D804-C3AE-4E7E-A62A-8D927536C836 Q23913233-A1A46E04-4E2A-4F51-87CC-A7365024B40B Q23914627-B6BA6D04-2032-47E7-8299-1FD744C447B7 Q23914977-2E00914A-2DF6-4D9D-980D-16E22A5E15C5 Q23916117-20A90623-3A01-4515-8425-36E8A12A3EC5 Q23916166-A25598B0-E683-45A7-966D-28757E5087F7 Q23916177-CAD38280-2FD7-473C-A860-83B3E909561F Q23916185-6E24B73E-F27C-424E-A4B8-FCAFA4837715 Q23916383-F24F5536-B0DF-47EF-874A-8CC7D30F367E Q23916393-C302BC9C-8C69-460C-96A2-213308323942 Q23916753-E45B9F7E-0D39-4CC2-BA1B-C7639EEC5373 Q23916774-0BBCA027-3E36-4811-9B2C-8BD5B7787E0F Q23916846-86BFD3D1-7FE0-4CBC-B785-C207B4EA65F9 Q23917410-E16257E9-D287-47F9-93EF-DB7994C40B62 Q23917411-72CD4F67-6EAD-4F5A-9F21-2E927E6AA02C Q23918028-C8746721-FCE6-4ED8-86DD-B885CB06793B Q23918086-46F76BA5-FA19-4E5B-A543-903BDD1345A5 Q23918284-8903A0AE-DDC9-4B89-9FC9-D354FD19E828 Q23919329-679D7F98-AF8E-413E-B910-97912C34ACEA Q23920668-B57875D7-7AEB-4CB7-861A-286C8FFDF2CF Q23920953-DE9EAAE9-A78F-4CF9-946A-8B32B21DD3E8 Q23922473-FECD8F46-4C58-4AA8-AE40-AC4AD590700B Q23923393-9CF76DC9-1AE9-4760-A64E-E7395B4E3C99 Q23923575-73237E26-FB5F-4787-9E1F-11ADEFA072FF Q24170384-60F11044-DDB4-4830-A898-EED0F36B1232 Q24170491-C3F30F77-FE90-4C9D-AD7A-63C431892A0F Q24536032-3AA1FCB0-294F-4726-B6FE-1B10DF0E26E6 Q24557518-7AE61783-6540-491A-A92A-7657C98C1A1C Q24853061-50E8B448-A92C-409C-9C5C-A8E17EFB0571 Q25932820-9E356C18-F5BB-4E06-855B-9747C7C1FEC9 Q28290077-2F6F3F35-D0D3-4D39-9C38-B865A3CD80AB Q28294393-AE3085D7-08B9-45DE-96AD-6C3C1D68E486 Q28384922-7F567B11-FF2C-46EB-857A-854854853508 Q28386699-8EBE5016-FA1E-4C1E-8FE9-C4D926BC58C4 Q28386885-B95E8A14-56EA-49C5-A128-895BBC5C9F30 Q28387517-B7FC155B-ADAA-42EC-AEBF-F486FA8FBA44

P2860

Skin as a route of exposure and sensitization in chronic beryllium disease

http://www.wikidata.org/entity/Q23920927

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Skin as a route of exposure and sensitization in chronic beryllium disease

@ast

Skin as a route of exposure and sensitization in chronic beryllium disease

@en

Skin as a route of exposure and sensitization in chronic beryllium disease

@en-gb

Skin as a route of exposure and sensitization in chronic beryllium disease

@nl

type

label

Skin as a route of exposure and sensitization in chronic beryllium disease

@ast

Skin as a route of exposure and sensitization in chronic beryllium disease

@en

Skin as a route of exposure and sensitization in chronic beryllium disease

@en-gb

Skin as a route of exposure and sensitization in chronic beryllium disease

@nl

prefLabel

Skin as a route of exposure and sensitization in chronic beryllium disease

@ast

Skin as a route of exposure and sensitization in chronic beryllium disease

@en

Skin as a route of exposure and sensitization in chronic beryllium disease

@en-gb

Skin as a route of exposure and sensitization in chronic beryllium disease

@nl

P1433

Q23920927-6AD9C3B6-D126-4DC1-9BB8-3DEDADAC4D5E

P1476

Q23920927-3D6DC9F5-C777-4A25-B665-01BBC7F5D5D4

P2093

Q23920927-374958C1-698F-4378-A85C-FE0A5A4B480D

Q23920927-6D22282E-3042-4139-BAD0-18AF54405C73

Q23920927-998BCEB0-EB62-4BBE-AD68-067CF61D8EA8

Q23920927-B1340C0F-EEFB-4EEA-9615-0EA407DBF2E0

Q23920927-E57C70D0-C7D3-4274-819D-4520B46A3676

P2860

Q23920927-05957F2E-F501-48EF-BCDB-886ED5BE4831

Q23920927-0C35BAB9-6511-4176-95A6-8668F3701D83

Q23920927-1329ACC4-44B6-45E9-9FFE-6172D64F2C06

Q23920927-17D0BDF3-8D44-40D7-ADD3-21B5A747A12A

Q23920927-2AC6A3CD-BB70-4DE5-925A-B5E6239DFAF3

Q23920927-3F055A70-C6B4-4CAC-B6E9-FD43B8580418

Q23920927-5795C896-A236-46EF-91F9-BA60481D138A

Q23920927-5C7BB04E-B75A-48DE-922E-6998BAB40550

Q23920927-5E4908B5-B244-4495-95F2-5FEECB98F76D

Q23920927-84A19333-22D8-49CB-9F13-9D2D03EF472C

P2880

Q23920927-A5C6D4BF-291C-4451-81B5-99275CF379D5

P304

Q23920927-FC60DF78-6AE8-42FB-9AA2-6C69ED3BBCB5

P31

Q23920927-30AA64EC-A5F4-4639-A59C-5FB7E81136B3

P3181

Q23920927-8244577B-1863-4629-8F7A-CB8C61546C96

P356

Q23920927-42A51A8B-406D-4AAD-938F-96B563579142

P407

Q23920927-49D76AEF-A832-4349-8134-DB702414C7CA

P433

Q23920927-4D761A26-C467-48C2-A045-0DBBA9510155

P478

Q23920927-F5DEEAC9-E6F1-4ABF-966E-BF04A071F83E

P50

Q23920927-1DE2E256-C934-4D1A-A26D-9301925839B2

Q23920927-D2E35386-8442-4624-AE9F-7BB33D52040C

P577

Q23920927-9344BCD3-4F51-4E5C-A740-66649EC4F584

Q23920927-E8F1AD4E-7CE3-452A-B06A-AFFC654BD2F1

P5875

Q23920927-7564ABFF-FD7D-479C-A847-C026D9C773F9

P698

Q23920927-01A3B62C-A1C2-4D04-85CC-F50C7FAF0995

P859

Q23920927-A0F94550-FBC7-4F8C-8147-A62AF048DD72

P921

Q23920927-1BA700EB-9B27-4F14-9D55-D17293FB7CAB

Q23920927-2FD66357-B5F0-4286-A441-185DE2747BB1

Q23920927-46F67419-E465-45AA-873F-22ED651B819C

Q23920927-6D1CBBE8-A9DA-4C1E-94B3-15998EC82CD0

Q23920927-70C7820D-517C-42D9-830F-FA9A4388C802

Q23920927-89025EEF-4539-4437-BA58-7356EB281236

Q23920927-90C7E76F-1418-4FDF-A8C3-8D8050D7153D

Q23920927-B86AB662-28EF-4C65-9B07-B3B2693BAC45

Q23920927-BE9639EC-7937-46AE-938F-1CC434B389BC

Q23920927-D43C0138-E93A-48C8-8716-C82D640BDA7D

P932

Q23920927-EEAC4486-90E1-47FE-A0F4-7B70254D6AA1

P3181

P356

P1433

Environmental Health Perspectives

P1476

Skin as a route of exposure and sensitization in chronic beryllium disease

@en

P2093

Brenda A. Rich

http://www.w3.org/2001/XMLSchema#string

Eric J. Adkins

http://www.w3.org/2001/XMLSchema#string

Karyn DePree

http://www.w3.org/2001/XMLSchema#string

Rebecca Salmen

http://www.w3.org/2001/XMLSchema#string

Sally S. Tinkle

http://www.w3.org/2001/XMLSchema#string

P2860

Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant

Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk

Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant

Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant

Aerosols generated during beryllium machining

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease

Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells

Investigation of follicular penetration of topically applied substances.

Epidemiology of beryllium sensitization and disease in nuclear workers.

Phagocytosis of antigens by Langerhans cells in vitro.

P2880

20033847

http://www.w3.org/2001/XMLSchema#string

P304

1202-1208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3321498

http://www.w3.org/2001/XMLSchema#string

P356

10.1289/EHP.5999

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

James M. Antonini

Jenny R. Roberts

P577

2003-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10676541

http://www.w3.org/2001/XMLSchema#string

P698

12842774

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

occupational exposure limit

exposure assessment

skin absorption

P932

1241575

http://www.w3.org/2001/XMLSchema#string